N/A
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Female
Breast Cancer, Lymphedema
Female
Breast Cancer, Lymphedema
Trial Information
Inclusion Criteria:
- unilateral arm lymphedema as a result of breast cancer treatment
- completion of breast cancer treatments
- arm lymphedema onset 3 months or more after surgery and persistent for at least 6
months
- in the maintenance phase of lymphedema treatment
Exclusion Criteria:
- women with recurrent cancer
- intercurrent diseases affecting the swollen arm
- lack of understanding of the Hebrew language
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Outcome Measure:
Improved arm volume measurement
Outcome Time Frame:
Weekly for five weeks
Safety Issue:
No
Authority:
Israel: Ministry of Health
Study ID:
0023-09-HYMC
NCT ID:
NCT00935714
Start Date:
August 2009
Completion Date:
Related Keywords:
- Breast Cancer
- Lymphedema
- Arm
- Lymphedema
- Breast Cancer
- Exercise
- Breast Cancer related Lymphedema
- Breast Neoplasms
- Lymphedema
Name | Location |
|---|
